| Indications | Strategy | Development Stage | ||||||
|---|---|---|---|---|---|---|---|---|
| Hit | Lead | Candidate | Pre-Clinical | Phase Ⅰ | Phase Ⅱ | Phasell Ⅲ | ||
| Breast cancer | Hybrid small molecule | |||||||
| Leukemia | PROTACs | |||||||
| Alzheimer’s disease | PROTACs | |||||||
| Small molecule | ||||||||
| Acute coronary syndrome | Hybrid small molecule | |||||||
| SARS-COV2 | Peptidomimetic | |||||||
| Retinal diseases (Dry AMD) | Small molecule | |||||||
| TB and non-infectious disease | Hybrid small molecule | |||||||
| Retinal diseases | Repurposing | |||||||
| Parkinson’s disease | HPAPI | |||||||
| Gastric cancer | Small molecule | |||||||
| Hair loss | Natural Product | |||||||
| Rheumatoid arthritis | Natural Product | |||||||
| Prostatits | Natural Product | |||||||